Select therapeutic use:

Dry eye:

Indications for: RESTASIS

To increase tear production in keratoconjunctivitis sicca-associated ocular inflammation.

Adult Dosage:

≥16yrs: 1 drop in each eye every 12hrs.

Children Dosage:

<16yrs: not established.

RESTASIS Warnings/Precautions:

Remove contact lenses before treatment; may reinsert 15mins after instillation. Pregnancy. Nursing mothers.

RESTASIS Classification:

Immunomodulator (partial)/ antiinflammatory.

RESTASIS Interactions:

Allow ≥15mins between dosing of lubricant eye drops.

Adverse Reactions:

Ocular burning, conjunctival hyperemia, discharge, epiphora, eye pain, foreign body sensation, pruritus, stinging, blurring.

Metabolism:

Hepatic.

Drug Elimination:

Fecal. Half-life: ~19 hours.

Generic Drug Availability:

NO

How Supplied:

Single-use vials (0.4mL)—30, 60; Multidose (5.5mL)—1

Ocular allergy/inflammation:

Indications for: RESTASIS

To increase tear production in keratoconjunctivitis sicca-associated ocular inflammation.

Adult Dosage:

≥16yrs: 1 drop in each eye every 12hrs.

Children Dosage:

<16yrs: not established.

RESTASIS Warnings/Precautions:

Remove contact lenses before treatment; may reinsert 15mins after instillation. Pregnancy. Nursing mothers.

RESTASIS Classification:

Immunomodulator (partial)/ antiinflammatory.

RESTASIS Interactions:

Allow ≥15mins between dosing of lubricant eye drops.

Adverse Reactions:

Ocular burning, conjunctival hyperemia, discharge, epiphora, eye pain, foreign body sensation, pruritus, stinging, blurring.

Metabolism:

Hepatic.

Drug Elimination:

Fecal. Half-life: ~19 hours.

Generic Drug Availability:

NO

How Supplied:

Single-use vials (0.4mL)—30, 60; Multidose (5.5mL)—1